California Public Employees Retirement System Halozyme Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

A detailed history of California Public Employees Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 228,859 shares of HALO stock, worth $12.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

228,859

Previous 241,568 5.26%

Holding current value

$12.8 Million

Previous $12.6 Million 3.52%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.3 - $64.42 $651,971 - $818,713	-12,709 Reduced 5.26%	228,859 $13.1 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $317,414 - $439,898	8,395 Added 3.6%	241,568 $12.6 Million
Q1 2024 Apr 30, 2024	SELL	$33.68 - $41.95 $235,928 - $293,859	-7,005 Reduced 2.92%	233,173 $9.49 Million
Q4 2023 Feb 01, 2024	SELL	$33.32 - $42.1 $335,632 - $424,073	-10,073 Reduced 4.03%	240,178 $8.88 Million
Q3 2023 Nov 02, 2023	BUY	$36.46 - $44.03 $82,800 - $99,992	2,271 Added 0.92%	250,251 $9.56 Million
Q2 2023 Aug 09, 2023	SELL	$30.28 - $38.74 $3.7 Million - $4.74 Million	-122,233 Reduced 33.02%	247,980 $8.94 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $312,860 - $530,319	-9,521 Reduced 2.51%	370,213 $14.1 Million
Q4 2022 Feb 08, 2023	BUY	$40.06 - $59.44 $2.77 Million - $4.11 Million	69,077 Added 22.24%	379,734 $21.6 Million
Q3 2022 Nov 09, 2022	BUY	$38.53 - $51.78 $1.79 Million - $2.41 Million	46,521 Added 17.61%	310,657 $12.3 Million
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $807,992 - $1.04 Million	-21,633 Reduced 7.57%	264,136 $11.6 Million
Q1 2022 May 04, 2022	SELL	$31.97 - $41.06 $762,004 - $978,665	-23,835 Reduced 7.7%	285,769 $11.4 Million
Q4 2021 Feb 10, 2022	SELL	$31.82 - $40.75 $179,178 - $229,463	-5,631 Reduced 1.79%	309,604 $12.4 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $10,617 - $12,811	276 Added 0.09%	315,235 $12.8 Million
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $724,832 - $957,547	-18,662 Reduced 5.59%	314,959 $14.3 Million
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $260,845 - $339,672	-6,602 Reduced 1.94%	333,621 $13.9 Million
Q4 2020 Feb 02, 2021	BUY	$25.81 - $43.62 $715,066 - $1.21 Million	27,705 Added 8.87%	340,223 $14.5 Million
Q3 2020 Nov 05, 2020	BUY	$25.74 - $29.63 $235,134 - $270,670	9,135 Added 3.01%	312,518 $8.21 Million
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $42,396 - $69,947	2,609 Added 0.87%	303,383 $8.13 Million
Q1 2020 May 12, 2020	SELL	$13.9 - $21.83 $3.31 Million - $5.2 Million	-238,428 Reduced 44.22%	300,774 $5.41 Million
Q4 2019 Jan 27, 2020	BUY	$14.93 - $19.53 $3.62 Million - $4.73 Million	242,426 Added 81.69%	539,202 $9.56 Million
Q3 2019 Oct 31, 2019	BUY	$15.2 - $17.69 $2.03 Million - $2.36 Million	133,400 Added 81.65%	296,776 $4.6 Million
Q2 2019 Aug 15, 2019	BUY	$14.75 - $17.26 $70,416 - $82,399	4,774 Added 3.01%	163,376 $2.81 Million
Q1 2019 May 03, 2019	SELL	$13.94 - $17.58 $29,274 - $36,918	-2,100 Reduced 1.31%	158,602 $2.55 Million
Q4 2018 Feb 08, 2019	SELL	$13.33 - $18.66 $260,988 - $365,344	-19,579 Reduced 10.86%	160,702 $2.35 Million
Q3 2018 Nov 13, 2018	SELL	$16.68 - $18.41 $145,466 - $160,553	-8,721 Reduced 4.61%	180,281 $3.28 Million
Q2 2018 Aug 15, 2018	SELL	$16.87 - $20.3 $107,934 - $129,879	-6,398 Reduced 3.27%	189,002 $3.19 Million
Q1 2018 May 11, 2018	SELL	$17.06 - $21.2 $160,364 - $199,280	-9,400 Reduced 4.59%	195,400 $3.83 Million
Q4 2017 Feb 06, 2018	BUY	$16.75 - $20.8 $118,925 - $147,680	7,100 Added 3.59%	204,800 $4.15 Million
Q3 2017 Nov 15, 2017	BUY	$11.76 - $17.4 $2.32 Million - $3.44 Million	197,700	197,700 $3.43 Million

Others Institutions Holding HALO

# of Institutions

539

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Halozyme Therapeutics, Inc. Transaction History